Substituted heterocyclic compounds
US7125876B2 · kind B2 · utility
1Cited by
13References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2003 |
| Grant date | Oct 24, 2006 |
| Priority date | — |
| Expiry date | Aug 10, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel heterocyclic compounds having the structurewhich are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useflul in the treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.